Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidemic Parotitis, Mumps”

112 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 112 results

Large-scale testing (Phase 3)Study completedNCT05065177
What this trial is testing

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Who this might be right for
Mumps
Sinovac Research and Development Co., Ltd. 1,140
Testing effectiveness (Phase 2)Study completedNCT00000815
What this trial is testing

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Who this might be right for
HIV InfectionsMeasles
National Institute of Allergy and Infectious Diseases (NIAID) 270
Large-scale testing (Phase 3)Study completedNCT00351923
What this trial is testing

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

Who this might be right for
MeaslesMumpsRubella+1 more
GlaxoSmithKline 330
Large-scale testing (Phase 3)Study completedNCT00226499
What this trial is testing

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

Who this might be right for
VaricellaChickenpox Vaccines
GlaxoSmithKline 5,803
Large-scale testing (Phase 3)Study completedNCT00985153
What this trial is testing

Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 3,927
Testing effectiveness (Phase 2)Study completedNCT00892775
What this trial is testing

Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds

Who this might be right for
MeaslesVaricellaMumps+1 more
GlaxoSmithKline 501
Large-scale testing (Phase 3)Study completedNCT00984295
What this trial is testing

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,913
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Testing effectiveness (Phase 2)UnknownNCT03133923
What this trial is testing

Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

Who this might be right for
Epidemic Parotitis,Mumps
Institute of Medical Biology, Chinese Academy of Medical Sciences 1,080
Not applicableStudy completedNCT01369394
What this trial is testing

Making Decisions About the Measles-Mumps-Rubella Vaccine

Who this might be right for
MeaslesMumpsRubella+1 more
University of Michigan 79
Not applicableStudy completedNCT00962819
What this trial is testing

Measles, Mumps, and Rubella (MMR) Immunity in College Students

Who this might be right for
MeaslesMumpsRubella
Sri Edupuganti, MD MPH 74
Large-scale testing (Phase 3)Study completedNCT01536405
What this trial is testing

Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,412
Post-approval studies (Phase 4)Study completedNCT02880865
What this trial is testing

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

Who this might be right for
Encephalitis, JapaneseMeaslesMumps+1 more
PATH 628
Post-approval studies (Phase 4)Study completedNCT00731965
What this trial is testing

Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis

Who this might be right for
Arthritis, Juvenile Rheumatoid
N.M. Wulffraat 140
Post-approval studies (Phase 4)Study completedNCT02325310
What this trial is testing

Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR

Who this might be right for
MeaslesRubellaMumps
Assistance Publique - Hôpitaux de Paris 14
Post-approval studies (Phase 4)Study completedNCT00312858
What this trial is testing

Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)

Who this might be right for
Hepatitis A Virus
Merck Sharp & Dohme LLC 653
Testing effectiveness (Phase 2)Study completedNCT04398706
What this trial is testing

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Who this might be right for
Pneumococcal ImmunisationDiphtheria ImmunisationTetanus Immunisation+8 more
Sanofi Pasteur, a Sanofi Company 852
Large-scale testing (Phase 3)Study completedNCT00192491
What this trial is testing

Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children

Who this might be right for
Influenza
MedImmune LLC 1,200
Large-scale testing (Phase 3)Study completedNCT01702428
What this trial is testing

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

Who this might be right for
RubellaMeaslesMumps
GlaxoSmithKline 5,016
Post-approval studies (Phase 4)Study completedNCT05399212
What this trial is testing

Composition for Treating Spermatogenesis and Semen Disorders / FPT-20

Who this might be right for
Spermatogenesis and Semen Disorders
Trieu, Nguyen Thi, M.D. 60
Load More Results